Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Ashwani Gujral of ashwanigujral.com recommends buying Tata Elxsi, Strides Shasun and UPL.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Sun Pharma and feels that all banking stocks are sell ideas.
Ashwani Gujral of ashwanigujral.com recommends selling Strides Shasun, Torrent Pharma and Aurobindo Pharma and feels that ITC may head lower and test Rs 260.
According to Sharmila Joshi of sharmilajoshi.com, one may hold Strides Shasun.
Ashwani Gujral of ashwanigujral.com recommends selling BPCL and advises buying State Bank of India and Axis Bank on dips.
Gaurav Bissa -Derivatives Analyst at LKP Securities recommends going long in Siemens and advises selling Strides Shasun.
Rajat Bose of rajatkbose.com recommends going long in Strides Shasun for a target of Rs 1,059.
Mehraboon Irani of Nirmal Bang Securities is of the view that one may prefer Alembic Pharmaceuticals from the pharma space.
Rahul Shah of Motilal Oswal is of the view that one can short Strides Shasun and Canara Bank and advises buying Voltas.
Vishal Malkan of malkansview.com suggests buying India Cements with a target of Rs 95.
Gaurang Shah of Geojit BNP Paribas Financial Services suggests holding Strides Shasun.
Ashish Kyal of wavesstrategy.com is of the view that one may hold Strides Shasun.
According to Sudarshan Sukhani of s2analytics.com, the correction in pharmaceutical stocks would be an opportunity.
Vishal Malkan of malkansview.com suggests holding Strides Shasun with a target of Rs 1400.
Shahina Mukadam, Independent Market Expert advises holding Strides Shasun.
Paras Bothra of Ashika Stock Broking recommends buying Marico with a target of Rs 460 and KPIT Tech with a target of Rs 190.
Gaurav Bissa of LKP Securities is of the view that advises selling Strides Arcolab.
Sudarshan Sukhani of s2analytics.com recommends buying Strides Arcolab and staying on the short side in Lupin.
Deepak Shenoy of Capitalmind.in likes Strides Arcolab for the long term.
Sudarshan Sukhani of s2analytics.com is of the view that Strides Arcolab may breakout.
Gaurav Ratnaparkhi of Sharekhan is of the view that one may buy Strides Arcolab with a target of Rs 1440.
Sudarshan Sukhani of s2analytics.com is of the view that one can go long in pharma stocks.
Chandan Taparia of Anand Rathi Securities advises buying Strides Arcolab.
Chandan Taparia of Anand Rathi Securities suggests buying Century Textiles and Strides Arcolab.
Manish Hathiramani of Deen Dayal Investments recommends buying Bajaj Auto, Bosch, Wockhardt, Syndicate Bank and Strides Arcolab.